Contents

Current Drug Therapy, Volume 7 - Number 2

EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]

, 7(2): 77 - 79

Michael W. Stewart


DOI: 10.2174/157488512800675977




Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs

, 7(2): 80 - 89

Michael W. Stewart


DOI: 10.2174/157488512800676002




Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration

, 7(2): 90 - 95

James P. Bolling


DOI: 10.2174/157488512800676039




Anti-VEGF Treatment of Diabetic Retinopathy

, 7(2): 96 - 100

Keye Wong


DOI: 10.2174/157488512800675968




Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions

, 7(2): 101 - 116

David J. Browning


DOI: 10.2174/157488512800675986




Utility of Non-Conventional Applications of Anti-VEGF Treatment in Selected Retinal Diseases

, 7(2): 117 - 122

Rebecca A. Manning, Charles P. Richards, Kishan Govind and Shree K. Kurup


DOI: 10.2174/157488512800676057




Anti-VEGF Treatment of Anterior Segment Disorders of the Eye

, 7(2): 123 - 125

Saiyid A. Hasan


DOI: 10.2174/157488512800676011




Anti-VEGF Treatment of Glaucoma

, 7(2): 126 - 130

Rick E. Bendel


DOI: 10.2174/157488512800675995




Complications of Anti-Vascular Endothelial Growth Factor Drugs

, 7(2): 131 - 137

Michael Tolentino


DOI: 10.2174/157488512800675959




Risk Factors Associated with Resistance in CTX-M Producing E. coli Isolates

, 7(2): 138 - 143

Milad Masaeli, Tayyebe Faraji, Rashid Ramazanzadeh, Nour Amirmozafari, Majid Mansouri and Behzad Mohsenpor


DOI: 10.2174/157488512800676020




“The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives

, 7(2): 144 - 149

Niraj S. Vyawahare, Varsha J. Bansode and Neeraj B. Munjal


DOI: 10.2174/157488512800676048




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science